Geron Corp. (GERN)
1.225
0.00 (0.00%)
USD |
NASDAQ |
Oct 09, 16:00
1.23
0.00 (0.00%)
After-Hours: 20:00
Geron Free Cash Flow : -114.76M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -114.76M |
| March 31, 2026 | -126.13M |
| December 31, 2025 | -110.95M |
| September 30, 2025 | -132.68M |
| June 30, 2025 | -178.14M |
| March 31, 2025 | -204.41M |
| December 31, 2024 | -219.30M |
| September 30, 2024 | -216.50M |
| June 30, 2024 | -208.58M |
| March 31, 2024 | -184.70M |
| December 31, 2023 | -168.57M |
| September 30, 2023 | -162.89M |
| June 30, 2023 | -141.61M |
| March 31, 2023 | -140.52M |
| December 31, 2022 | -127.81M |
| September 30, 2022 | -114.76M |
| June 30, 2022 | -107.94M |
| March 31, 2022 | -97.04M |
| December 31, 2021 | -95.76M |
| September 30, 2021 | -86.12M |
| June 30, 2021 | -78.64M |
| March 31, 2021 | -73.41M |
| December 31, 2020 | -67.05M |
| September 30, 2020 | -64.88M |
| June 30, 2020 | -61.67M |
| Date | Value |
|---|---|
| March 31, 2020 | -57.84M |
| December 31, 2019 | -44.24M |
| September 30, 2019 | -36.80M |
| June 30, 2019 | -30.71M |
| March 31, 2019 | -26.44M |
| December 31, 2018 | -21.02M |
| September 30, 2018 | -22.40M |
| June 30, 2018 | -20.67M |
| March 31, 2018 | -20.62M |
| December 31, 2017 | -20.56M |
| September 30, 2017 | -16.80M |
| June 30, 2017 | -18.93M |
| March 31, 2017 | -20.13M |
| December 31, 2016 | -18.43M |
| September 30, 2016 | -23.08M |
| June 30, 2016 | -21.37M |
| March 31, 2016 | -22.07M |
| December 31, 2015 | -24.20M |
| September 30, 2015 | 9.532M |
| June 30, 2015 | 9.965M |
| March 31, 2015 | 11.01M |
| December 31, 2014 | 9.219M |
| September 30, 2014 | -25.89M |
| June 30, 2014 | -27.13M |
| March 31, 2014 | -29.93M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Precigen, Inc. | -115.22M |
| Editas Medicine, Inc. | -120.55M |
| Agenus, Inc. | -98.50M |
| Amgen, Inc. | 10.18B |
| Anika Therapeutics, Inc. | 0.562M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -15.83M |
| Cash from Investing (Quarterly) | 8.295M |
| Cash from Financing (Quarterly) | 1.384M |
| Free Cash Flow Per Share (Quarterly) | -0.0239 |
| Free Cash Flow to Equity (Quarterly) | -15.98M |
| Free Cash Flow to Firm (Quarterly) | -8.904M |
| Free Cash Flow Yield | -14.01% |